Masarykova univerzita přírodovědecká fakulta diplomová práce brno 2017 Veronika Krmeská masarykova univerzita

Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., Rassenti, L., Kipps, T., Negrini, M., Bullrich, F. & Croce, C.M. 2002. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 99(24):15524-15529.
Calin, G.A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S.E., Iorio, M.V., Visone, R., Sever, N.I., Fabbri, M., Iuliano, R., Palumbo, T., Pichiorri, F., Roldo, C., Garzon, R., Sevignani, C., Rassenti, L., Alder, H., Volinia, S., Liu, C.G., Kipps, T.J., Negrini, M. & Croce, C.M. 2005. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med, 353(17):1793-1801.
Chen, L., Huynh, L., Apgar, J., Tang, L., Rassenti, L., Weiss, A. & Kipps, T.J. 2008. ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia. Blood, 111(5):2685-2692.
Choi, M.Y. & Kipps, T.J. 2012. Inhibitors of B-cell receptor signaling for patients with B-cell malignancies. Cancer J, 18(5):404-410.
Chrousos, G.P. & Kino, T. 2005. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE, 2005(304):pe48.
DeOcesano-Pereira, C., Amaral, M.S., Parreira, K.S., Ayupe, A.C., Jacysyn, J.F., Amarante-Mendes, G.P., Reis, E.M. & Verjovski-Almeida, S. 2014. Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis. Nucleic Acids Res, 42(13):8343-8355.
DeOcesano-Pereira, C., Amaral, M.S., Parreira, K.S., Ayupe, A.C., Jacysyn, J.F., Amarante-Mendes, G.P., Reis, E.M. & Verjovski-Almeida, S. 2016. Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis. Nucleic Acids Res, 44(19):9518.
Dong, Y., Liang, G., Yuan, B., Yang, C., Gao, R. & Zhou, X. 2015. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol, 36(3):1477-1486.
Döhner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M. & Lichter, P. 2000. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med, 343(26):1910-1916.
Döhner, H., Stilgenbauer, S., Döhner, K., Bentz, M. & Lichter, P. 1999. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med (Berl), 77(2):266-281.
Engreitz, J.M., Pandya-Jones, A., McDonel, P., Shishkin, A., Sirokman, K., Surka, C., Kadri, S., Xing, J., Goren, A., Lander, E.S., Plath, K. & Guttman, M. 2013. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science, 341(6147):1237973.
Fellig, Y., Ariel, I., Ohana, P., Schachter, P., Sinelnikov, I., Birman, T., Ayesh, S., Schneider, T., de Groot, N., Czerniak, A. & Hochberg, A. 2005. H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol, 58(10):1064-1068.
Fulci, V., Chiaretti, S., Goldoni, M., Azzalin, G., Carucci, N., Tavolaro, S., Castellano, L., Magrelli, A., Citarella, F., Messina, M., Maggio, R., Peragine, N., Santangelo, S., Mauro, F.R., Landgraf, P., Tuschl, T., Weir, D.B., Chien, M., Russo, J.J., Ju, J., Sheridan, R., Sander, C., Zavolan, M., Guarini, A., Foà, R. & Macino, G. 2007. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood, 109(11):4944-4951.
Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M. & Dalla-Favera, R. 1991. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 88(12):5413-5417.
Gong, C. & Maquat, L.E. 2011. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature, 470(7333):284-288.
Guo, F., Li, Y., Liu, Y., Wang, J. & Li, G. 2010. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai), 42(3):224-229.
Gutschner, T., Hämmerle, M., Eissmann, M., Hsu, J., Kim, Y., Hung, G., Revenko, A., Arun, G., Stentrup, M., Gross, M., Zörnig, M., MacLeod, A.R., Spector, D.L. & Diederichs, S. 2013. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res, 73(3):1180-1189.
Herishanu, Y., Pérez-Galán, P., Liu, D., Biancotto, A., Pittaluga, S., Vire, B., Gibellini, F., Njuguna, N., Lee, E., Stennett, L., Raghavachari, N., Liu, P., McCoy, J.P., Raffeld, M., Stetler-Stevenson, M., Yuan, C., Sherry, R., Arthur, D.C., Maric, I., White, T., Marti, G.E., Munson, P., Wilson, W.H. & Wiestner, A. 2011. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood, 117(2):563-574.
Hu, L., Wu, Y., Tan, D., Meng, H., Wang, K., Bai, Y. & Yang, K. 2015. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res, 34:7.
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M.J., Kenzelmann-Broz, D., Khalil, A.M., Zuk, O., Amit, I., Rabani, M., Attardi, L.D., Regev, A., Lander, E.S., Jacks, T. & Rinn, J.L. 2010. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell, 142(3):409-419.

Isin, M., Ozgur, E., Cetin, G., Erten, N., Aktan, M., Gezer, U. & Dalay, N. 2014. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta, 431:255-259.
Ji, P., Diederichs, S., Wang, W., Böing, S., Metzger, R., Schneider, P.M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., Thomas, M., Berdel, W.E., Serve, H. & Müller-Tidow, C. 2003. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene, 22(39):8031-8041.
Kino, T., Hurt, D.E., Ichijo, T., Nader, N. & Chrousos, G.P. 2010. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal, 3(107):ra8.
Li, R., Zhu, H. & Luo, Y. 2016. Understanding the Functions of Long Non-Coding RNAs through Their Higher-Order Structures. Int J Mol Sci, 17(5).
Li, X., Zhu, M., Brasier, A.R. & Kudlicki, A.S. 2015. Inferring genome-wide functional modulatory network: a case study on NF-κB/RelA transcription factor. J Comput Biol, 22(4):300-312.
Lottin, S., Adriaenssens, E., Dupressoir, T., Berteaux, N., Montpellier, C., Coll, J., Dugimont, T. & Curgy, J.J. 2002. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis, 23(11):1885-1895.
Ma, X.Y., Wang, J.H., Wang, J.L., Ma, C.X., Wang, X.C. & Liu, F.S. 2015. Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells. BMC Genomics, 16:676.
Matouk, I.J., Mezan, S., Mizrahi, A., Ohana, P., Abu-Lail, R., Fellig, Y., Degroot, N., Galun, E. & Hochberg, A. 2010. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta, 1803(4):443-451.
Matutes, E. & Polliack, A. 2000. Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Clin Exp Hematol, 4(1):22-47.
Mraz, M., Pospisilova, S., Malinova, K., Slapak, I. & Mayer, J. 2009. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma, 50(3):506-509.
Musilova, K. & Mraz, M. 2015. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia, 29(5):1004-1017.

Nourse, J., Firpo, E., Flanagan, W.M., Coats, S., Polyak, K., Lee, M.H., Massague, J., Crabtree, G.R. & Roberts, J.M. 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature, 372(6506):570-573.
Núnêz, C., Bashein, A.M., Brunet, C.L., Hoyland, J.A., Freemont, A.J., Buckle, A.M., Murphy, C., Cross, M.A., Lucas, G., Bostock, V.J. & Brady, G. 2000. Expression of the imprinted tumour-suppressor gene H19 is tightly regulated during normal haematopoiesis and is reduced in haematopoietic precursors of patients with the myeloproliferative disease polycythaemia vera. J Pathol, 190(1):61-68.
Patel, V., Chen, L.S., Wierda, W.G., Balakrishnan, K. & Gandhi, V. 2014. Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia. Leuk Lymphoma, 55(4):899-910.
Penny, G.D., Kay, G.F., Sheardown, S.A., Rastan, S. & Brockdorff, N. 1996. Requirement for Xist in X chromosome inactivation. Nature, 379(6561):131-137.
Petlickovski, A., Laurenti, L., Li, X., Marietti, S., Chiusolo, P., Sica, S., Leone, G. & Efremov, D.G. 2005. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood, 105(12):4820-4827.
Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W.J. & Pandolfi, P.P. 2010. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature, 465(7301):1033-1038.
Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. & Pasternack, B.S. 1975. Clinical staging of chronic lymphocytic leukemia. Blood, 46(2):219-234.
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D.A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S.R., Simmons, A., Clines, G.A., Sartiel, A., Gatti, R.A., Chessa, L., Sanal, O., Lavin, M.F., Jaspers, N.G., Taylor, A.M., Arlett, C.F., Miki, T., Weissman, S.M., Lovett, M., Collins, F.S. & Shiloh, Y. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 268(5218):1749-1753.
Shain, K.H., Dalton, W.S. & Tao, J. 2015. The tumor microenvironment shapes hallmarks of mature B-cell malignancies. Oncogene, 34(36):4673-4682.
Tano, K., Mizuno, R., Okada, T., Rakwal, R., Shibato, J., Masuo, Y., Ijiri, K. & Akimitsu, N. 2010. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett, 584(22):4575-4580.
Tripathi, V., Ellis, J.D., Shen, Z., Song, D.Y., Pan, Q., Watt, A.T., Freier, S.M., Bennett, C.F., Sharma, A., Bubulya, P.A., Blencowe, B.J., Prasanth, S.G. & Prasanth, K.V. 2010. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell, 39(6):925-938.
Tripathi, V., Shen, Z., Chakraborty, A., Giri, S., Freier, S.M., Wu, X., Zhang, Y., Gorospe, M., Prasanth, S.G., Lal, A. & Prasanth, K.V. 2013. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet, 9(3):e1003368.
Tsai, M.C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J.K., Lan, F., Shi, Y., Segal, E. & Chang, H.Y. 2010. Long noncoding RNA as modular scaffold of histone modification complexes. Science, 329(5992):689-693.
Wallace, J.A. & Felsenfeld, G. 2007. We gather together: insulators and genome organization. Curr Opin Genet Dev, 17(5):400-407.
Wilusz, J.E., Freier, S.M. & Spector, D.L. 2008. 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell, 135(5):919-932.
Wu, X.S., Wang, X.A., Wu, W.G., Hu, Y.P., Li, M.L., Ding, Q., Weng, H., Shu, Y.J., Liu, T.Y., Jiang, L., Cao, Y., Bao, R.F., Mu, J.S., Tan, Z.J., Tao, F. & Liu, Y.B. 2014. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol Ther, 15(6):806-814.
Yang, G., Lu, X. & Yuan, L. 2014. LncRNA: a link between RNA and cancer. Biochim Biophys Acta, 1839(11):1097-1109.
Yang, Y., Zhou, X. & Jin, Y. 2013. ADAR-mediated RNA editing in non-coding RNA sequences. Sci China Life Sci, 56(10):944-952.
Yildirim, E., Kirby, J.E., Brown, D.E., Mercier, F.E., Sadreyev, R.I., Scadden, D.T. & Lee, J.T. 2013. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell, 152(4):727-742.
Young, T.L., Matsuda, T. & Cepko, C.L. 2005. The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol, 15(6):501-512.
Zarnegar, B.J., Wang, Y., Mahoney, D.J., Dempsey, P.W., Cheung, H.H., He, J., Shiba, T., Yang, X., Yeh, W.C., Mak, T.W., Korneluk, R.G. & Cheng, G. 2008. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol, 9(12):1371-1378.
Zhang, E.B., Yin, D.D., Sun, M., Kong, R., Liu, X.H., You, L.H., Han, L., Xia, R., Wang, K.M., Yang, J.S., De, W., Shu, Y.Q. & Wang, Z.X. 2014. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis, 5:e1243.